左心室内密切肉瘤伪装成一种良性质量
Qi Ouyang1, Yong Jiang2, Xia He2
1Fuwai Hospital Shenzhen, Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China; Shenzhen University, Shenzhen, Guangdong, China.
JACC. Case reports
|March 10, 2026
概括
初级心脏肉瘤,像内肉瘤一样,可以在成像上模仿良性质量. MDM2基因测试对于准确诊断模两可的左侧心脏质量至关重要,使得及时和救命治疗.
科学领域:
- 心血管病理学心血管病理学
- 在瘤学瘤学.
- 诊断成像 诊断成像 诊断成像
背景情况:
- 初级心脏瘤是一种罕见且具有攻击性的恶性瘤.
- 术前诊断是具有挑战性的,因为模仿良性疾病,如有组织的血栓.
- 内部肉瘤是一种亚型,可以呈现出误导性的成像特征.
研究的目的:
- 要突出诊断在区分主性心脏肉瘤和良性质群体的诊断挑战.
- 强调识别特定成像"红旗"对于高等级的肉瘤的重要性.
- 倡导将MDM2基因测试纳入模两可的左侧心脏质量的诊断工作中.
主要方法:
- 一个45岁男性的病例介绍,他患有运动性呼吸障碍.
- 胸外心声扫描显示出一个大,化的左心室质量.
- 切割后的组织病理学和MDM2放大证实了内肉瘤.
主要成果:
- 一个化,无血管的左侧心脏质量,通常暗示良性病理,被发现是一种侵略性的内肉瘤.
- 患者的初始呈现模仿了有组织的血栓,延迟了最终的诊断.
- 扩大MDM2是确认恶性介质细胞瘤诊断的关键.
结论:
- 经典的良性成像特征可以掩盖高等级的心脏肉瘤.
- MDM2遗传测试对于明确诊断模两可的左侧心脏质量至关重要.
- 通过综合基因检测及时诊断有助于适当的基因切除,避免管理延误.
相关概念视频
Mitral Stenosis I: Introduction
1.0K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Mitral Valve Prolapse I: Introduction
820
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
820
Mitral Valve Prolapse II: Assessment and Management
918
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
918
Mitral Stenosis II: Clinical features and Diagnostic Tests
374
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
374
Cardiomyopathy III: Hypertrophic Cardiomyopathy
603
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Cardiomyopathy I: Introduction and Classification
741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741


